These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18284599)

  • 1. Which carboxypeptidase determines the antifibrinolytic potential?
    Gils A
    J Thromb Haemost; 2008 May; 6(5):846-7. PubMed ID: 18284599
    [No Abstract]   [Full Text] [Related]  

  • 2. The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.
    Walker JB; Bajzar L
    J Biol Chem; 2004 Jul; 279(27):27896-904. PubMed ID: 15128744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basic carboxypeptidases of blood: significance for coagulology].
    Timofeev АV
    Biomed Khim; 2016; 62(2):141-9. PubMed ID: 27143370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxypeptidase U at the interface between coagulation and fibrinolysis.
    Schatteman K; Goossens F; Leurs J; Verkerk R; Scharpé S; Michiels JJ; Hendriks D
    Clin Appl Thromb Hemost; 2001 Apr; 7(2):93-101. PubMed ID: 11292199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway.
    Bajzar L
    Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2511-8. PubMed ID: 11116046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice.
    Zhou Q; Zhao L; Shao Z; Declerck P; Leung LLK; Morser J
    J Thromb Haemost; 2022 Jan; 20(1):238-244. PubMed ID: 34626062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen.
    Wang W; Hendriks DF; Scharpé SS
    J Biol Chem; 1994 Jun; 269(22):15937-44. PubMed ID: 8195249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma.
    Broze GJ; Higuchi DA
    Blood; 1996 Nov; 88(10):3815-23. PubMed ID: 8916945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic (cleaving arginine and lysine residues) metallocarboxypeptidase of mammalian tissue: structure, properties and function].
    Vernigora AN; Gengin MT
    Ukr Biokhim Zh (1978); 1998; 70(4):16-24. PubMed ID: 9848196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity.
    Walker JB; Binette TM; Mackova M; Lambkin GR; Mitchell L; Bajzar L
    J Thromb Haemost; 2008 May; 6(5):848-55. PubMed ID: 18221361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism of the antifibrinolytic activity of plasma carboxypeptidase B.
    Sakharov DV; Plow EF; Rijken DC
    J Biol Chem; 1997 May; 272(22):14477-82. PubMed ID: 9162090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Properties of basic (splitting off arginine and lysine residues) carboxypeptidases and their role in the functioning of biologically active peptides].
    Vernigora AN; Gengin MT
    Ukr Biokhim Zh (1978); 1993; 65(1):3-12. PubMed ID: 8351739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels.
    Brouwers GJ; Vos HL; Leebeek FW; Bulk S; Schneider M; Boffa M; Koschinsky M; van Tilburg NH; Nesheim ME; Bertina RM; Gómez Garcia EB
    Blood; 2001 Sep; 98(6):1992-3. PubMed ID: 11565542
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor.
    Mao SS; Colussi D; Bailey CM; Bosserman M; Burlein C; Gardell SJ; Carroll SS
    Anal Biochem; 2003 Aug; 319(1):159-70. PubMed ID: 12842119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not.
    Sato T; Miwa T; Akatsu H; Matsukawa N; Obata K; Okada N; Campbell W; Okada H
    J Immunol; 2000 Jul; 165(2):1053-8. PubMed ID: 10878383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
    Walker JB; Bajzar L
    J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of commercially available procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) assays.
    Heylen E; Willemse JL; Hendriks DF
    J Thromb Haemost; 2011 Jul; 9(7):1407-9. PubMed ID: 21535389
    [No Abstract]   [Full Text] [Related]  

  • 19. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N.
    Campbell WD; Lazoura E; Okada N; Okada H
    Microbiol Immunol; 2002; 46(2):131-4. PubMed ID: 11939578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat stability of carboxypeptidase R of experimental animals.
    Komura H; Shimomura Y; Yumoto M; Katsuya H; Okada N; Okada H
    Microbiol Immunol; 2002; 46(3):217-23. PubMed ID: 12008932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.